These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15795671)

  • 1. [Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C].
    Khalil A; Lucidarme D; Desurmont P; Hamdan-Khalil R; Filoche B
    Gastroenterol Clin Biol; 2005 Feb; 29(2):193-6. PubMed ID: 15795671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
    Moisseiev E; Goldenberg D; Kurtz S
    Ophthalmic Surg Lasers Imaging; 2011 Sep; 42 Online():e91-3. PubMed ID: 21899250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
    Abdelmalek MF; Liu C; Valentine JF
    Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
    Halász T; Farkas A; Tolvaj G; Horváth G
    Orv Hetil; 2006 Feb; 147(7):321-4. PubMed ID: 17489160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cough associated with interferon/ribavirin therapy for hepatitis C.
    Dicpinigaitis PV; Weiner FR
    J Clin Pharm Ther; 2011 Jun; 36(3):416-8. PubMed ID: 21545621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function.
    Georgiopoulos G; Alexopoulou A; Pouriki S; Vasilieva L; Laina A; Bampatsias D; Mani I; Kontogiannis C; Tousoulis D; Stamatelopoulos K; Dourakis SP
    Hellenic J Cardiol; 2019; 60(2):143-145. PubMed ID: 31146885
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe liver injury associated with simeprevir plus pegylated interferon/ribavirin therapy in a patient with treatment-naïve genotype 1b hepatitis C virus: a case report.
    Igawa T; Fushimi S; Matsuo R; Ikeda F; Nouso K; Yoshino T; Nakatsukasa H
    Clin J Gastroenterol; 2014 Oct; 7(5):465-70. PubMed ID: 26184030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The adherence in the treatment of chronic hepatitis C].
    Pawłowska M; Halota W
    Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of inflammatory bowel disease in chronic hepatitis C patients treated with pegylated interferon and ribavirin: coincidence or consequence?
    Salgueiro P; Lago P; Pedroto I
    J Crohns Colitis; 2013 Jun; 7(5):e194. PubMed ID: 23219260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M; Dainichi T; Gondo H; Urabe K
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?
    Blacklaws H; Gardner A; Usher K
    J Clin Nurs; 2011 May; 20(9-10):1215-24. PubMed ID: 21371144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus.
    Paraná R; Cruz M; Lyra L; Cruz T
    J Viral Hepat; 2000 Sep; 7(5):393-5. PubMed ID: 10971829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C and Crohn's disease: nosocomial infection treatment with PEG-interferon plus ribavirin.
    Salcedo-Mora X; Maté J; Medina J; Nam Cha SJ; Gisbert JP; Moreno-Otero R
    Digestion; 2006; 73(4):210-4. PubMed ID: 16883071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adult case with onset of celiac disease during chronic hepatitis C antiviral treatment.
    Ioniţă-Radu F; Bucurică S; Costache R; Nuţă P; Stanciu S
    Rom J Intern Med; 2010; 48(1):105-8. PubMed ID: 21180248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin for chronic hepatitis C].
    Watanabe T; Inoue M; Harada K; Homma N; Uchida M; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
    Nihon Shokakibyo Gakkai Zasshi; 2006 Sep; 103(9):1061-6. PubMed ID: 16953104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal lactic acidosis in a HIV-positive patient treated with interferon and ribavirin for chronic hepatitis C.
    Guyader D; Poinsignon Y; Cano Y; Saout L
    J Hepatol; 2002 Aug; 37(2):289-91. PubMed ID: 12127440
    [No Abstract]   [Full Text] [Related]  

  • 20. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.